Abstract-The interaction of ceruletide (CER) and apomorphine (APO) was studied in mice. APO and CER were injected subcutaneously.
The discovery of cholecystokinin (CCK) like immunoreactivity in a subpopulation of midbrain dopamine (DA)-containing neurons (1) suggests that the coexistence of CCK and dopamine in neurons must have some physio logical significance. However, so far reported pharmacological studies on CCK-DA inter action have shown conflicting results. For example, when apomorphine (APO), a dopamine agonist, was used at a lower dose which depresses the locomotor activity in rats, the depressive effect of APO was an tagonized by the sulfated octapeptide CCK (CCK8) (2) , unsulphated CCK8 and cerule tide (CER) (3) which were administered centrally (3). However, in mice, subcu taneously administered CER potentiated the depressive effects of a lower dose of APO (4). On the other hand, in rats, when APO at a dose high enough to increase locomotor activity was administered, CCK did not affect (2) or antagonized (3) the behavioral effects of APO. CCK8 has been also shown to antagonize (5) the behavioral effects of L-DOPA in rats, while it potentiated dopamine-mediated behavior in rats (6). The aim of the present work was to discuss the interaction of CCK and DA Using CER, a stronger substitute for CCK, and APO as a dopamine agonist. Neuronal activity in the brain was evaluated by observing the neuronal uptake of 2-deoxy-D-(14C)-glucose (2-DG).
Materials and Methods
Male ddY strain mice weighing 20 g were used. Locomotor activity of the animals was measured in wheelcages (LB-5 (I), Line Seiki Co., Ltd.) for 30 min, from 10 to 40 min after the subcutaneous injection of drugs. The number of cage rotations during each 5 min period was counted (Fig. 1) ) and stored overnight at -60°C. The next day, the brains were cut into 20 um slices in serial fashion using a cryostatmicrotome (Tissue-Tek) at -20°C . The sections were thaw mounted on warm slides, dried and exposed to X-ray film for two weeks together with an autoradio graphic microscale standard (120 /em level strips). Autoradiograms obtained by develop ing the X-ray film were taken by video camera (Hitachi, VK-C150). The digital data were treated with PC-9801 VM4 (Nippon Electric Co.) to display them as false color images on a display screen. The amount of 2-DG uptake in a certain locus in the brain was determined by computer operation as follows: A certain area in the false color image from an autoradiogram was delineated by a computer and the optical density within the delineated circle was converted by a computer program into nCi per gram tissue through comparing its density with that in the microscale standard. In order to identify what location in the brain each slice was from, it was stained by cresyl violet solution (Nissl stain), and the preparation was matched to the coronary sections of the brain in the atlas of the mouse brain published by Sidman et al. (7).
Significant differences between data were assessed by Student's t-test. 
Results
As shown in Fig. 1 , in the present wheel cage experiments, APO showed bell-shaped activity in the dose-effect relation with regard to the depression of the locomotor activity in mice. That is, 0.05 mg/kg of APO produced an insignificant depressive effect, 0.1 and 1 mg/kg of APO produced significant de pressive effects and 0.1 mg/kg showed a larger effect than 1 mg/kg.
CER slightly depressed the locomotor activity at a dose of 0.02 mg/kg. The combi nation of APO and CER produced larger depressive effects than those produced by the corresponding doses of APO. That is, CER augmented APO with regard to the de pression of the locomotor activity in mice.
The effects of APO, CER and the combi nation of APO and CER on the neuronal uptake of 2-DG are shown in Table 1 . APO inhibited the 2-DG uptake in most loci listed in the table in both the doses of 0.05 and 1.0 mg/kg.
However, the inhibition of 2-DG uptake by APO was stronger at the dose of 0.05 mg/kg than at 1.0 mg/kg. The 2-DG uptake at each locus was affected in a different manner by the lower dose (0.05 mg/ kg) and the higher dose (1.0 mg/kg) of APO. Especially in the pontine nuclei, 1 mg/kg of APO significantly enhanced the 2-DG uptake in neurons. CER (0.02 mg/kg) caused no general inhibition in 2-DG uptake in the loci examined. It increased the 2-DG uptake in the olfactory cortex and hypothalamic nuclei, but decreased the 2-DG uptake in the frontal cortex and caudate putamen. The combi nation of APO and CEP, produced a surprising increase in 2-DG uptake in neurons at every locus listed in Table 1 . Discussion APO, a dopamine agonist, is well-known to act on both pre and postsynaptic dopamine receptors on the brain neurons. In lower doses, APO acts predominantly on the presynaptic dopamine receptors, causing the inhibition of dopamine release from nerve endings, which results in the depression of locomotor activity (8, 9), while in higher doses, it stimulates also postsynaptic dopa mine receptors, leading to the enhancement of locomotor activity (10-12).
In the present experiments, 50 and 100 iig/kg of APO dose-dependently inhibited the locomotor activity in mice. However, a higher dose, 1 mg/kg, of APO produced a smaller depressive effect than 100 /cg/kg of APO. The smaller effect of APO at the higher dose (1 mg/kg) may be explained in the following way. The effect of 1 mg/kg of APO is composed of dual actions, one acting on the presynaptic dopamine receptors, which produces depres sion in locomotor activity, and the other acting on the postsynaptic dopamine recep tors, which enhances locomotor activity. Thus the net effect induced by 1 mg/kg of APO was depression in the locomotor activity, and the depressive effect was larger than that by 0.1 mg/kg, but slightly smaller than that by 0.5 mg/kg of APO.
CER slightly depressed the locomotor activity in mice at a subcutaneous dose of 20 i g/kg. The combined administration of APO and CER augmented the depressive effect. These results were in accord with those reported by Vasar et al. (4). Systemically administered CER is reported to inhibit the release of dopamine from dopaminergic neurons (13), but this inhibition is likely to be induced by an indirect action of CER, since systemically administered CER can not enter the brain as is described below. However, there is still a possibility that the effect of APO may be inhibited by CER.
The 2-DG method has been well establi shed by Sokoloff et al. (14) . The increase in the 2-DG uptake in neurons indicates the increase in the metabolic rate in the neurons. In the experiments using rats, blood glucose is determined every five min and the rate of 2-DG uptake is corrected by using the blood glucose level. In mice, however, it is difficult to repeatedly determine the blood glucose. Therefore, in the present work, we assessed the 2-DG uptake by comparing those in control and drug-administerd mice. The results on the effects of APO and CER on 2 DG uptake in neurons are intriguing, es pecially when APO and CER were coadminis tered. As shown in Table 1 , APO produced general inhibition of 2-DG uptake in most regions of the brain, and the higher dose (1 mg/kg) of APO produced rather smaller effects on 2-DG uptake, as was expected from the effects of APO on locomotor activity. As noted before, a higher dose (1 mg/kg) of APO seems to show dual actions of acting on presynaptic and postsynaptic receptors and have opposite effects of stimulating and inhibiting 2-DG uptake in neurons. The net effects of the dual actions caused the in hibition of 2-DG uptake in most regions. On the other hand, CER (20 ug/kg) exerted complex effects on 2-DG uptake in the neurons. 2-DG uptake in the frontal cortex and caudate putamen was inhibited, but that in the olfactory cortex and hypothalamic nuclei was increased. Zetler reported that peripherally administered CER can produce various pharmacological effects such as hypothermia (15), antinociception (16) and satiety (17). Therefore, it is difficult to cor relate the effect of CER on 2-DG uptake with each of its pharmacological effects. Coadmin istration of APO and CER produced un expected effects on 2-DG uptake, causing marked increases in 2-DG uptake in every region examined. This enhanced 2-DG uptake is difficult to correlate with the de pressed locorotor activity at present. Evidence indicates that peripherally adminis tered CER does not directly act on the central nervous system, since peripherally adminis tered CER can not produce central effects after vagotomy (18). The above considera tions suggest that CER and APO produce their depressive locomotor effects through different modes of action. We expected that the interaction between APO and CER on locomotor effects might be explained through examining their effects on 2-DG uptake in the brain, but the results were rather too ambi guous to be explained. Further experiments are under way.
